Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $45.8428 (-2.46%) ($45.8086 - $47.1509) on Mon. Oct. 13, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.42% (three month average) | RSI | 41 | Latest Price | $45.8428(-2.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) SPY(47%) VT(44%) XBI(41%) QQQ(40%) | Factors Impacting ABBV price | ABBV will decline at least -0.71% in a week (0% probabilities). VIXM(-24%) TLT(-15%) UUP(-7%) GLD(-5%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.71% (StdDev 1.42%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
1 - 5 Day Possible Target | $43.67(-4.74%) | Resistance Level | $49.04 | 5 Day Moving Average | $47.71(-3.91%) | 10 Day Moving Average | $48.26(-5.01%) | 20 Day Moving Average | $49.04(-6.52%) | To recent high | -9.4% | To recent low | 3.8% | Market Cap | $80.88b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |